What could scientists do with synthetic human genome?

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

The recent closed-door meeting about creating genomes from scratch prompted a lot of hand-wringing among scientists and other critics fearful of a future full of lab-grown humans.

But such a science fiction scenario is not what the work is all about, researchers and entrepreneurs who attended the meeting told STAT. Synthesizing genomes should help scientists better understand the fundamentals of biology and disease, they said.

The genome contains the instructions for life. And while scientists can decipher the complete sequence of DNA that makes up a human genome, trying to build the 3 billion nucleotides letter by letter would be a test of how much we know about it.

“Moving beyond reading DNA to writing DNA is a natural next step,” Francis Collins, director of the National Institutes of Health, told STAT in an email.

Pamela Silver, a Harvard bioengineer who was invited to but did not attend the meeting, said that taking the genome apart (with new gene-editing techniques like CRISPR) and putting it together (through synthesis) are “complementary” methods: “No one is better than the other.”

Read full, original post: Forget the sci-fi horror stories: Here’s what we could really learn from a synthetic genome

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Screenshot-2026-05-08-at-3.40.33-PM
Seeds of power: China turns to genetic engineering to become global superpower
Farmers can talk to plants
Farmers are a major source of misinformation—about farming
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot 2026-05-08 at 3.01
Transforming farming and nutrition with AI and robotics? Larry Ellison’s half-billion-dollar Hawaii greenhouse dream goes bust
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.